However, in NASH-HCC, their function is often suppressed due to an immunosuppressive TIME, which is characterized by chronic inflammation, regulatory T cell (Treg) infiltration, and increased expression of immune checkpoint molecules such as PD-1 and CTLA-4[26, 27]. Here, CTLA4 is linked to metabolic dysfunction-associated steatohepatitis.